SCC072
UM-SCC-104 HPV-16 Positive Squamous Carcinoma Cell Line
Human
Sinónimos:
University Michigan Squamous Cell Carcinoma, UMSCC104, H&N squamous cell carcinoma cell line, Head and neck squamous cell carcinoma cell line, HNSCC
About This Item
Productos recomendados
product name
UM-SCC-104 HPV-16 Positive Squamous Carcinoma Cell Line, UM-SCC-104 is a unique head and neck squamous carcinoma (HNSCC) cell line derived from a 56-year old male with a recurrent oral cavity tumor naturally infected with high-risk human papillomavirus (HPV-16).
biological source
human
Quality Level
technique(s)
cell culture | mammalian: suitable
shipped in
liquid nitrogen
General description
THIS PRODUCT IS ONLY AVAILABLE FOR SALE TO ACADEMIC INSTITUTIONS OR NOT-FOR-PROFIT ENTITIES FOR USE UNDER THIS LIMITED USE LABEL LICENSE. FOR INFORMATION ON COMMERCIAL LICENSING OF UM-SCC CELLS, INCLUDING LICENSING TO COMMERCIAL ENTITIES, PLEASE CONTACT: licensing@emdmillipore.com
Head and neck squamous-cell carcinoma (HNSCC) is the 6th most common type of cancer world-wide. The cancer may occur in the lip, oral cavity, nasal cavity, paranasal sinuses, salivary glands, pharynx and larynx. Risk factors include smoking, alcohol consumption, betel nut chewing, wood dust exposures and human papilloma virus (HPV) infections. Approximately 15% of HNSCC contain genomic DNA from HPV. In particular, HPV-16 occurs in 90-95% of all HPV-positive HNSCC cases. In oral and pharynx cancer, HPV DNA is found in the tonsils in 45-67% of the cases. HPV DNA is found in 13-25% of the cases in the hypopharynx, 12-18% in the oral cavity and 3-7% in the larynx.
UM-SCC-104 is a unique head and neck squamous carcinoma cell line derived from a 56-year old male with a recurrent oral cavity tumor naturally infected with high-risk human papillomavirus (HPV-16). The patient had a history of moderate consumption of alcohol and smoking (20 pack/year). UM-SCC-104 contains a small population of ALDH+ cancer stem cells. The tumor from which the cell line was derived failed to respond to initial chemoradiation therapy and thus UM-SCC-104 is a useful model for preclinical studies of aggressive non-responsive tumors and may be used for studying the interplay between viral and carcinogen-related pathways in tumor progression.
UM-SCC-104 was established at the University of Michigan with written informed consent obtained from the patient and with the approval of the study by the Medical School Institutional Review Board.
Reference:
1) Carey, T., et al. (2012) Genotyping of 73 UM-SCC head and neck squamous cell carcinoma cell lines. Head Neck. 2010 April; 32(4): 417–426.
Cell Line Description
Application
Infectious Diseases
Inflammation & Immunology
Apoptosis & Cancer
Components
Quality
• Cells are tested by PCR and are positive for HPV-16 and negative for Hepatitis A, B, C and HIV-1 & 2 viruses.
• Cells are negative for mycoplasma contamination.
• Each lot of cells are genotyped by STR analysis to verify the unique identity of the cell line.
Storage and Stability
Disclaimer
Storage Class
6.2 - Infectious substances
wgk_germany
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
Certificados de análisis (COA)
Busque Certificados de análisis (COA) introduciendo el número de lote del producto. Los números de lote se encuentran en la etiqueta del producto después de las palabras «Lot» o «Batch»
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.
Póngase en contacto con el Servicio técnico